Page 1 of 15Free preview · 1–5

About this document

This research preprint presents K-NeSyNet, a neuro-symbolic framework for personalized oncology treatment recommendation. It combines imaging, clinical text, and genomic features with a Multi-Modal Oncology Knowledge Graph constructed from TCGA, DGIdb, KEGG, and NCCN guidelines. An adaptive fusion network integrates graph-based neural predictions with symbolic signals for guideline support, mutation-target matching, and contraindications. Experiments involving 4,781 patients across 10 cancer types compare the framework with eight baselines and report leading F1@10, NDCG@10, and Jaccard scores, but mixed clinical safety results. The document includes ablation studies, hyperparameter sensitivity analysis, and a score-decomposed explanation case study. Prospective clinical validation remains future work.

Free preview text

The first 5 pages, shown as text so search engines and readers can find this document.

Page 1

Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph Liuqing Yanga, Hong Wana, Jiangping Zhub, Pei Zhoub and Zhongjian Wanga,∗ aBCPM Data Limited, Building A, 1st Floor, 1480 North Tianfu Avenue, Chengdu High-tech Zone, Chengdu, 610041, Sichuan, China bCollege of Computer Science, Sichuan University, (Wangjiang Campus) No. 24 South Section 1, Yihuan Road, Chengdu, 610065, Sichuan, China A R T I C L E I N F O Keywords: Neuro-Symbolic AI Knowledge Graph Treatment Recommendation Precision Oncology Explainable AI Multi-Modal Learning A B S T R A C T Personalized oncology treatment recommendation is a critical clinical task that requires in- tegrating complex, multi-modal patient data with established medical knowledge to ensure both accuracy and safety. While deep learning models excel at capturing latent patterns from high-dimensional data, their opaque decision-making processes and inability to strictly enforce clinical constraints hinder their adoption in high-stakes medical domains. Conversely, traditional rule-based systems offer high interpretability but struggle to scale with complex, heterogeneous data. To address these challenges, we propose the Knowledge-driven Neuro-Symbolic Network (K-NeSyNet), a novel framework for personalized oncology treatment recommendation. K- NeSyNet is grounded in a newly constructed Multi-Modal Oncology Knowledge Graph (MM- OKG) that unifies genomic mutations, medical imaging features, clinical text, and structured medical guidelines from publicly available sources including TCGA, DGIdb, KEGG, and NCCN guidelines. The core innovation of K-NeSyNet is a three-channel differentiable symbolic rea- soning mechanism that explicitly models guideline recommendations, mutation-target matching, and contraindication penalties for each patient-drug pair. These symbolic signals are dynamically fused with the outputs of a knowledge-aware graph attention neural reasoning module via an adaptive gated fusion network. Crucially, the fusion gate learns to balance neural and symbolic confidence in a patient-specific manner, while contraindication evidence enters both the symbolic score and a dedicated safety objective to down-weight clinically risky drugs. Extensive experi- ments on a real-world multi-modal oncology dataset comprising 4,781 patients across 10 cancer types demonstrate that K-NeSyNet consistently outperforms eight state-of-the-art baselines. Specifically, K-NeSyNet achieves the highest F1@10 of 0.9227, NDCG@10 of 0.9656, and Jaccard similarity of 0.9366, while maintaining competitive Clinical Guideline Consistency. Ablation studies confirm the indispensable role of each component, with the removal of the fusion gate causing the most significant performance degradation. Furthermore, K-NeSyNet provides transparent, score-decomposed explanations for its recommendations, offering a crucial step toward trustworthy AI-assisted clinical decision support. 1. Introduction Precision oncology has fundamentally transformed cancer treatment by tailoring therapeutic strategies to the molecular and clinical characteristics of individual patients [1, 2]. Unlike the traditional “one-size-fits-all” paradigm, precision oncology leverages genomic profiling, medical imaging, and clinical records to identify the most effective and least harmful treatment for each patient. However, the exponential growth in multi-modal patient data, the complexity of drug-gene-disease interactions, and the rapid evolution of clinical guidelines present significant challenges for clinicians seeking to make optimal treatment decisions in a timely manner [3, 4]. Computational approaches, particularly deep learning, have shown remarkable promise in automating aspects of clinical decision-making [5–7]. Knowledge graph (KG)-based methods further enhance recommendation quality by incorporating structured biomedical knowledge, such as drug-drug interactions and drug-disease associations [8–10]. Despite these advances, existing methods suffer from three critical limitations when applied to the oncology treatment recommendation task. ∗Corresponding author yanglq@bcpmdata.com (L. Yang); med@bcpmdata.com (H. Wan); zjp16@scu.edu.cn (J. Zhu); zhoupei@scu.edu.cn (P. Zhou); wangzj@bcpmdata.com (Z. Wang) ORCID(s): 0009-0002-9623-5877 (L. Yang); 0009-0003-4523-7263 (H. Wan); 0000-0002-9756-5264 (J. Zhu); 0000-0003-1631-3637 (P. Zhou); 0000-0003-2247-3848 (Z. Wang) Yang et al.: Preprint submitted to Elsevier Page 1 of 15 .CC-BY 4.0 International licenseIt is made available under a display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to(which was not certified by peer review)for this preprint The copyright holderthis version posted June 2, 2026.;https://doi.org/10.64898/2026.06.01.26354443doi:medRxiv preprint

Page 2

K-NeSyNet: Knowledge-Driven Neuro-Symbolic Reasoning for Oncology Treatment Recommendation First, most current models are unimodal or bimodal, relying primarily on electronic health records (EHR) or molecular data alone, while neglecting the rich complementary information available in medical imaging and clinical narratives. In oncology, treatment decisions are inherently multi-modal: a pathologist examines histopathology slides, a radiologist reviews CT scans, a molecular biologist interprets genomic mutations, and a clinician synthesizes all of these with the patient’s clinical history [11]. Failing to integrate these diverse modalities leads to an incomplete patient representation. Second, existing deep learning approaches operate as “black boxes” that lack the ability to explicitly encode and enforce clinical rules. In oncology, certain drugs are strictly contraindicated for patients with specific genetic mutations or comorbidities (e.g., immunotherapy monotherapy is generally not recommended as first-line treatment for EGFR- mutant non-small cell lung cancer). A purely neural model may learn statistical correlations that approximate these rules but cannot guarantee strict adherence, posing serious safety risks [12, 13]. Third, current methods provide limited explainability. Clinicians require transparent reasoning paths to trust and adopt AI-generated recommendations. A recommendation system that simply outputs a ranked list of drugs without explaining why a particular drug is recommended (or not recommended) is unlikely to gain clinical acceptance [14]. To address these challenges, we propose the Knowledge-driven Neuro-Symbolic Network (K-NeSyNet), a novel framework that synergistically combines the pattern recognition strengths of neural networks with the logical rigor and transparency of symbolic reasoning. K-NeSyNet is built upon a newly constructed Multi-Modal Oncology Knowledge Graph (MM-OKG) that integrates patient-level multi-modal features (imaging, text, genomics) with structured biomedical knowledge from TCGA [15], DGIdb [16], KEGG [17], and NCCN clinical guidelines. The core innovation of K-NeSyNet lies in its three-channel differentiable symbolic reasoning module, which computes explicit symbolic scores for each patient-drug pair along three clinically meaningful dimensions: (1) guideline support, which measures whether a drug is recommended by clinical guidelines for the patient’s cancer type; (2) target matching, which evaluates whether the drug targets any of the patient’s mutated genes; and (3) contraindication penalty, which identifies drugs that are contraindicated given the patient’s specific mutation profile. These symbolic scores are then dynamically integrated with the neural predictions from a knowledge-aware graph attention network (KGAT) through an adaptive gated fusion network. The fusion gate is conditioned on both the patient’s multi-modal embedding and the relative magnitudes of the neural and symbolic scores, enabling patient- specific balancing of data-driven and knowledge-driven signals. Crucially, contraindication evidence is injected into both the symbolic score and a dedicated safety objective, so clinically risky drugs are consistently down-weighted during learning and inference. Our main contributions are summarized as follows: • We propose K-NeSyNet, a neuro-symbolic framework that integrates multi-modal patient representations with differentiable symbolic reasoning for personalized oncology treatment recommendation. • We design a three-channel symbolic reasoning module (guideline, target-matching, contraindication) coupled with an adaptive gated fusion network that dynamically balances neural and symbolic predictions in a patient- specific manner. • We construct MM-OKG, a comprehensive multi-modal oncology knowledge graph integrating data from TCGA, DGIdb, KEGG, and NCCN guidelines, encompassing 4,781 patients, 15,615 entities, and 22,167 triples. • We conduct extensive experiments demonstrating that K-NeSyNet outperforms eight state-of-the-art baselines in both recommendation accuracy and clinical safety, while providing transparent, score-decomposed explanations. 2. Related Work 2.1. Knowledge Graph-Based Recommendation Knowledge graphs have been widely adopted in recommendation systems to provide rich auxiliary information beyond user-item interactions. KGNN [8] employs graph neural networks to aggregate neighborhood information in a KG, enabling the model to capture high-order structural patterns. MKR [9] proposes a multi-task learning framework that jointly trains KG embedding and recommendation, sharing latent features between the two tasks. KGAT [10] introduces an attentive message-passing scheme over the KG, allowing the model to discriminate the importance of different neighbors during aggregation. More recently, heterogeneous graph-based approaches [18] have been applied Yang et al.: Preprint submitted to Elsevier Page 2 of 15 .CC-BY 4.0 International licenseIt is made available under a display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to(which was not certified by peer review)for this preprint The copyright holderthis version posted June 2, 2026.;https://doi.org/10.64898/2026.06.01.26354443doi:medRxiv preprint

Page 3

K-NeSyNet: Knowledge-Driven Neuro-Symbolic Reasoning for Oncology Treatment Recommendation to electronic health records, demonstrating the potential of graph attention mechanisms in clinical settings. While these methods effectively leverage KG structure for general recommendation, they do not incorporate domain-specific clinical rules or multi-modal patient data, limiting their applicability in the medical domain. 2.2. Medication Recommendation Medication recommendation has emerged as an important subfield of clinical decision support. GAMENet [5] constructs a drug-drug interaction (DDI) graph and uses a graph-augmented memory module to generate safe drug combinations. SafeDrug [6] further improves safety by incorporating a global DDI graph into the training objective, explicitly penalizing unsafe drug combinations. COGNet [7] introduces a copy-or-generate mechanism that leverages historical medication records to improve recommendation accuracy. Recent work has also explored drug combination synergy prediction using deep learning [19] and knowledge graph-driven drug repurposing [20]. While these methods represent significant progress in safe medication recommendation, they are primarily designed for general medication scenarios and do not address the unique challenges of oncology, such as the need to integrate genomic mutation profiles, medical imaging, and cancer-specific clinical guidelines. 2.3. Neuro-Symbolic AI in Healthcare Neuro-symbolic AI seeks to combine the learning capabilities of neural networks with the reasoning capabilities of symbolic systems [21, 22]. In healthcare, this paradigm has shown promise for tasks requiring both data-driven pattern recognition and adherence to established medical knowledge. For instance, knowledge-infused learning has been applied to integrate clinical guidelines into neural models for disease diagnosis [23]. However, most existing neuro-symbolic approaches in healthcare either use symbolic knowledge only as a regularization signal during training or employ a simple additive combination of neural and symbolic outputs. Neuro-symbolic systems have also been applied to link prediction on biomedical knowledge graphs [24]. Our work advances this line of research by proposing a dynamic, patient-specific fusion mechanism with explicit safety enforcement, specifically tailored for the oncology treatment recommendation task. 2.4. Multi-Modal Learning in Medicine Multi-modal learning has gained significant attention in medical AI, driven by the availability of diverse data modalities including medical images, clinical text, and genomic data [25]. Recent work has demonstrated the benefits of integrating imaging and genomic data for cancer prognosis [26] and treatment response prediction. Gated fusion networks have been proposed to adaptively weight modality contributions in multi-modal settings [27], and attention mechanisms have been explored for precision medicine applications [28]. However, most multi-modal medical models focus on classification or prognosis tasks rather than treatment recommendation, and few integrate structured knowledge graphs with multi-modal patient representations. K-NeSyNet addresses this gap by constructing a unified multi-modal knowledge graph that serves as the foundation for both neural and symbolic reasoning. 3. Methodology In this section, we present the K-NeSyNet framework in detail. As illustrated in Fig. 1, K-NeSyNet consists of four core components: (1) Multi-Modal Oncology Knowledge Graph (MM-OKG) construction, (2) Multi-Modal Patient Encoder, (3) Dual-Channel Reasoning Engine (neural and symbolic), and (4) Adaptive Gated Fusion Network. Yang et al.: Preprint submitted to Elsevier Page 3 of 15 .CC-BY 4.0 International licenseIt is made available under a display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to(which was not certified by peer review)for this preprint The copyright holderthis version posted June 2, 2026.;https://doi.org/10.64898/2026.06.01.26354443doi:medRxiv preprint

Page 4

K-NeSyNet: Knowledge-Driven Neuro-Symbolic Reasoning for Oncology Treatment Recommendation Figure 1: The overall architecture of the Knowledge-driven Neuro-Symbolic Network (K-NeSyNet). The framework consists of three main components: (1) a Multi-Modal Patient Encoder that integrates medical imaging, clinical text, and genomic mutations; (2) parallel reasoning paths including a Knowledge-Aware Graph Attention Network (KGAT) for neural pattern recognition and a Differentiable Symbolic Reasoning Module with three clinically meaningful channels (guideline matching, mutation-target matching, and contraindication penalty); and (3) an Adaptive Gated Fusion Network that dynamically balances neural and symbolic signals while incorporating safety-aware contraindication penalties. 3.1. Problem Formulation Let  = {𝑝1, 𝑝2, … , 𝑝𝑁 } denote the set of 𝑁 patients and  = {𝑑1, 𝑑2, … , 𝑑𝑀 } denote the set of 𝑀 candidate drugs. Each patient 𝑝𝑖 is associated with multi-modal features: imaging features 𝐱𝑖𝑚𝑔 𝑖 ∈ ℝ512, clinical text embeddings 𝐱𝑡𝑥𝑡 𝑖 ∈ ℝ768, and genomic mutation profiles 𝐱𝑔𝑒𝑛 𝑖 ∈ ℝ256. The knowledge graph  = (, ,  ) consists of entities , relation types , and triples  ⊆  ×  × . The goal is to learn a scoring function 𝑓 (𝑝𝑖, 𝑑𝑗 ) ∈ [0, 1] that predicts the appropriateness of drug 𝑑𝑗 for patient 𝑝𝑖, considering both data-driven patterns and clinical knowledge. 3.2. Multi-Modal Oncology Knowledge Graph (MM-OKG) We construct the MM-OKG by integrating data from four publicly available sources: TCGA Clinical and Genomic Data. We retrieve clinical records and somatic mutation profiles for 4,781 patients across 10 cancer types from The Cancer Genome Atlas (TCGA) via the NCI Genomic Data Commons (GDC) API [15]. Each patient record includes demographics, cancer type, staging information, treatment history, and a list of somatic mutations. Drug-Gene Interactions. We obtain drug-gene interaction data from DGIdb v5 [16] , resulting in structured triples of the form (drug, targets, gene). Biological Pathways. We retrieve 20 cancer-related signaling pathways from the KEGG database [17] via its REST API, establishing gene-pathway associations. Clinical Guidelines. We encode treatment recommendations from NCCN clinical guidelines as structured rules mapping cancer types and molecular subtypes to recommended drug regimens. The resulting MM-OKG contains 15,615 entities, 15 relation types, and 22,167 triples. Entity types include patients, drugs (80), diseases (40), genes (10,586), and guidelines (128). Relation types include diagnosed_with, has_mutation, treated_with, targets, interacts_with, belongs_to_pathway, and guideline_recommends, among others. Yang et al.: Preprint submitted to Elsevier Page 4 of 15 .CC-BY 4.0 International licenseIt is made available under a display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to(which was not certified by peer review)for this preprint The copyright holderthis version posted June 2, 2026.;https://doi.org/10.64898/2026.06.01.26354443doi:medRxiv preprint

Page 5

K-NeSyNet: Knowledge-Driven Neuro-Symbolic Reasoning for Oncology Treatment Recommendation 3.3. Multi-Modal Patient Encoder The Multi-Modal Patient Encoder transforms heterogeneous patient features into a unified representation. For each modality 𝑚 ∈ {𝑖𝑚𝑔, 𝑡𝑥𝑡, 𝑔𝑒𝑛}, we apply a modality-specific linear projection followed by layer normalization and ReLU activation: 𝐡𝑚 𝑖 = ReLU(LayerNorm(𝐖𝑚𝐱𝑚 𝑖 + 𝐛𝑚)) (1) where 𝐖𝑚 ∈ ℝ𝐷×𝑑𝑚 and 𝐛𝑚 ∈ ℝ𝐷 are learnable parameters, 𝑑𝑚 is the input dimension of modality 𝑚, and 𝐷 is the unified embedding dimension. To dynamically weight the contribution of each modality based on its informativeness for a given patient, we employ a cross-modal attention mechanism: 𝛼𝑚 𝑖 = exp(𝐰⊤ 𝑎𝑡𝑡𝐡𝑚 𝑖 ) ∑𝑚′∈{𝑖𝑚𝑔,𝑡𝑥𝑡,𝑔𝑒𝑛} exp(𝐰⊤ 𝑎𝑡𝑡𝐡𝑚′ 𝑖 ) (2) where 𝐰𝑎𝑡𝑡 ∈ ℝ𝐷 is a learnable attention vector. The final patient embedding is the weighted sum: 𝐡𝑖 = ∑ 𝑚∈{𝑖𝑚𝑔,𝑡𝑥𝑡,𝑔𝑒𝑛} 𝛼𝑚 𝑖 𝐡𝑚 𝑖 (3) This attention mechanism allows the model to adaptively emphasize the most relevant modality for each patient. For instance, genomic features may be more informative for patients with actionable mutations, while imaging features may be more critical for patients where tumor morphology drives treatment decisions. 3.4. Knowledge-Aware Neural Reasoning Module The neural reasoning module leverages the KG structure to compute data-driven drug scores. We employ a multi- head graph attention network (GAT) [29] that operates on the MM-OKG to learn entity embeddings that capture both local neighborhood structure and global graph patterns. For each entity 𝑒 ∈ , we initialize its embedding 𝐞(0) ∈ ℝ𝐷 and iteratively update it through 𝐿 layers of graph attention: 𝐞(𝑙+1) = MultiHeadGAT(𝑙)(𝐞(𝑙), {𝐞(𝑙) 𝑛 ∶ 𝑛 ∈  (𝑒)}) (4) where  (𝑒) denotes the neighbors of entity 𝑒 in the KG. Each attention head computes: 𝛽(𝑙) 𝑒,𝑛 = exp(LeakyReLU(𝐚(𝑙)⊤[𝐖(𝑙)𝐞(𝑙)‖𝐖(𝑙)𝐞(𝑙) 𝑛 ])) ∑𝑛′∈ (𝑒) exp(LeakyReLU(𝐚(𝑙)⊤[𝐖(𝑙)𝐞(𝑙)‖𝐖(𝑙)𝐞(𝑙) 𝑛′ ])) (5) After 𝐿 layers of message passing, we obtain the final drug embedding 𝐝(𝐿) 𝑗 for each drug 𝑑𝑗 . The neural score for patient-drug pair (𝑝𝑖, 𝑑𝑗 ) is computed as: 𝑠𝑛𝑒𝑢𝑟𝑎𝑙 𝑖𝑗 = 𝜎(𝐡⊤ 𝑖 𝐖𝑠𝑐𝑜𝑟𝑒𝐝(𝐿) 𝑗 ) (6) where 𝐖𝑠𝑐𝑜𝑟𝑒 ∈ ℝ𝐷×𝐷 is a learnable bilinear scoring matrix and 𝜎(⋅) is the sigmoid function. 3.5. Differentiable Symbolic Reasoning Module The symbolic reasoning module computes explicit, interpretable scores for each patient-drug pair along three clinically meaningful channels. Channel 1: Guideline Support Score. This channel evaluates whether drug 𝑑𝑗 is recommended by clinical guidelines for patient 𝑝𝑖’s cancer type and stage: 𝑠𝑔𝑢𝑖𝑑𝑒 𝑖𝑗 = 𝟙[∃ guideline 𝑔 ∈  ∶ recommends(𝑔, 𝑑𝑗 , cancer_type(𝑝𝑖), stage(𝑝𝑖))] (7) In practice, this is implemented as a differentiable lookup in the guideline knowledge base, returning 1.0 if the drug is guideline-supported and 0.0 otherwise. Yang et al.: Preprint submitted to Elsevier Page 5 of 15 .CC-BY 4.0 International licenseIt is made available under a display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to(which was not certified by peer review)for this preprint The copyright holderthis version posted June 2, 2026.;https://doi.org/10.64898/2026.06.01.26354443doi:medRxiv preprint

Tags

Doxxly editorial guide

Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph: summary, contents and background

This guide helps you understand the scope of Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.

Summary and overview

Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph is a 15-page documentcredited to Gideon N. Oakfield. This research preprint presents K-NeSyNet, a neuro-symbolic framework for personalized oncology treatment recommendation. It combines imaging, clinical text, and genomic features with a Multi-Modal Oncology Knowledge Graph constructed from TCGA, DGIdb, KEGG, and NCCN guidelines. An adaptive fusion network integrates graph-based neural predictions with symbolic signals for guideline support, mutation-target matching, and contraindications. Experiments involving 4,781 patients across 10 cancer types compare the framework with eight baselines and report leading F1@10, NDCG@10, and Jaccard scores, but mixed clinical safety results. The document includes ablation studies, hyperparameter sensitivity analysis, and a score-decomposed explanation case study. Prospective clinical validation remains future work. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.

The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Neuro-Symbolic AI, Knowledge Graph, Treatment Recommendation, Precision Oncology, Explainable AI, Multi-Modal Learning, Clinical Decision Support, Research Preprint with the related resources linked below.

Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.

Key topics and reader takeaways

The catalogue connects this document with Neuro-Symbolic AI, Knowledge Graph, Treatment Recommendation, Precision Oncology, Explainable AI, Multi-Modal Learning, Clinical Decision Support, Research Preprint. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.

A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.

Table of contents and reading guide

The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 15 pages in the player.

  1. Part 1

    Neuro-Symbolic AI

    Use this section of the reading guide to identify how Neuro-Symbolic AI appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  2. Part 2

    Knowledge Graph

    Use this section of the reading guide to identify how Knowledge Graph appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  3. Part 3

    Treatment Recommendation

    Use this section of the reading guide to identify how Treatment Recommendation appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  4. Part 4

    Precision Oncology

    Use this section of the reading guide to identify how Precision Oncology appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  5. Part 5

    Explainable AI

    Use this section of the reading guide to identify how Explainable AI appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  6. Part 6

    Multi-Modal Learning

    Use this section of the reading guide to identify how Multi-Modal Learning appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  7. Part 7

    Clinical Decision Support

    Use this section of the reading guide to identify how Clinical Decision Support appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

  8. Part 8

    Research Preprint

    Use this section of the reading guide to identify how Research Preprint appears in Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, note important terms, and connect the subject to the wider purpose of the work.

When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.

About Gideon N. Oakfield

Doxxly credits Gideon N. Oakfield as the author or creator of Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.

Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.

About the source organisation

The recorded source for this item is medrxiv.org. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.

Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.

Visit medrxiv.org

How to read and use this document

Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.

The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.

If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.

Research questions to consider

As you read Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.

A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.

Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.

Explore more Medicine & Wellbeing resources

Frequently asked questions about Knowledge-Driven Neuro-Symbolic Reasoning for Personalized Oncology Treatment Recommendation Based on Multi-Modal Medical Knowledge Graph

Practical answers about reading, downloading and understanding this document on Doxxly.

More in Medicine & Wellbeing